NEOG Neogen Corporation
$12.12▼ -2.81%
Healthcare
Other
After hours
$12.05▼ -0.58%
Oct 28, 5:19 PM ET
Volume 3.62M
Avg Volume (10D) 2.71M
Key Metrics & Fundamentals
Market Cap
$2.65B
P/E Ratio
–
Div Yield
0.00%
52W Range
5.37 - 14.26
% vs 50 MA
-0.85%
% vs 200 MA
16.63%
RSI-14
49.5
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.44
Free Cash Flow
$4.70M
Gross Rev
$222.80M
Gross Profit
$105.50M
EBITDA
$29.70M
COGS
$117.30M
Operating Exp
$107.30M
Operating Income
-$1.80M
EBIT
-$1.80M
Pretax Income
-$14.90M
Net Income
-$11.90M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News

3 Reasons to sell NEOG and 1 stock to buy instead
StockStory · Oct 23, 2026 8:32 PM ET

NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
Zacks · Oct 20, 2026 11:36 AM ET

NEOG Q3 Deep Dive: Commercial Execution, Innovation, and Operational Progress Shape Outlook
StockStory · Oct 19, 2026 11:44 AM ET

Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
Zacks · Oct 12, 2026 7:55 AM ET

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Zacks · Oct 9, 2026 8:31 AM ET

Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product
Simply Wall St. · Oct 8, 2026 12:19 PM ET
Neogen Eyes Up To Low-Double-Digit Revenue Growth by Fiscal 2031
MT Newswires · Oct 8, 2026 5:01 AM ET

The 5 Most Interesting Analyst Questions From Neogen’s Q3 Earnings Call
StockStory · Oct 8, 2026 3:20 AM ET

Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
MarketBeat · Oct 7, 2026 10:02 PM ET
Financial Overview - Income Statement
Quarterly
Aug 2026
See NEOG's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.